Cytokinetics, Incorporated earnings per share and revenue

CYTK earnings per share for the last quarter are -1.36 USD whereas the estimation was -1.23 USD which accounts for -10.16% surprise. Company revenue for the same period amounts to 463.00 k USD despite the estimated figure of 1.21 M USD. Estimated earnings per share for the next quarter are -1.25 USD, and revenue is expected to reach 10.26 M USD. Also watch annual changes over time to get a bigger picture of CYTK earnings per share and revenue dynamics.